Synergy Pharmaceuticals to Begin Trading on The NASDAQ Global Market

[at noodls] – NEW YORK, Feb. 11, 2013 — Synergy Pharmaceuticals Inc. (Nasdaq:SGYP), a developer of new drugs to treat gastrointestinal disorders and diseases, today announced that its common stock has been approved … more

View todays social media effects on SGYPW

View the latest stocks trending across Twitter. Click to view dashboard

See who Synergy is hiring next, click here to view